US Stock MarketDetailed Quotes

CRISPR Therapeutics (CRSP)

Watchlist
  • 57.990
  • +2.270+4.07%
Close Apr 17 16:00 ET
  • 58.010
  • +0.020+0.03%
Post 20:01 ET
5.59BMarket Cap-8.96P/E (TTM)

CRISPR Therapeutics (CRSP) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
Discovering, developing and commercializing therapies derived from or incorporating genome-editing3.51M100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
Switzerland3.51M100.00%
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More